The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
Open accessAbstract
Cancer is a complex disease displaying a variety of cell states and phenotypes. This diversity, known as cancer cell plasticity, confers cancer cells the ability to change in response to their environment, leading to increased tumor diversity and drug resistance. This review explores the intricate landscape of cancer cell plasticity, offering a deep dive into the cellular, molecular, and genetic mechanisms that underlie this phenomenon. Cancer cell plasticity is intertwined with processes such as epithelial-mesenchymal transition and the acquisition of stem cell–like features. These processes are pivotal in the development and progression of tumors, contributing to the multifaceted nature of cancer and the challenges associated with its treatment. Despite significant advancements in targeted therapies, cancer cell adaptability and subsequent therapy-induced resistance remain persistent obstacles in achieving consistent, successful cancer treatment outcomes. Our review delves into the array of mechanisms cancer cells exploit to maintain plasticity, including epigenetic modifications, alterations in signaling pathways, and environmental interactions. We discuss strategies to counteract cancer cell plasticity, such as targeting specific cellular pathways and employing combination therapies. These strategies promise to enhance the efficacy of cancer treatments and mitigate therapy resistance. In conclusion, this review offers a holistic, detailed exploration of cancer cell plasticity, aiming to bolster the understanding and approach toward tackling the challenges posed by tumor heterogeneity and drug resistance. As articulated in this review, the delineation of cellular, molecular, and genetic mechanisms underlying tumor heterogeneity and drug resistance seeks to contribute substantially to the progress in cancer therapeutics and the advancement of precision medicine, ultimately enhancing the prospects for effective cancer treatment and patient outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–251 of 251
(2022) · Stem Cells International · doi:10.1155/4162 · Cited by 100
Bromodomain Drug Discovery – the Past, the Present, and the Future
Pervaiz, M., Mishra, P., & Günther, S. (2018) · The Chemical Record · doi:10.1002/tcr.201800074 · Cited by 96
Reguart, N., Rosell, R., Cardenal, F., Cardona, A. F., Isla, D., Palmero, R., Morán, T., Rolfo, C. D., Pallarès, M. C., Insa, A., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.02.011 · Cited by 95
Preferential Utilization of Imp7/8 in Nuclear Import of Smads
Yao, X., Chen, X., Cottonham, C., & Xu, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801320200 · Cited by 94
Gerlach, D., Tontsch-Grunt, U., Baum, A., Popow, J., Scharn, D., Hofmann, M. H., Engelhardt, H., Kaya, O., Beck, J., Schweifer, N., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0150-2 · Cited by 94
MicroRNA functional network in pancreatic cancer: From biology to biomarkers of disease
Wang, J., & Sen, S. (2011) · Journal of Biosciences · doi:10.1007/s12038-011-9083-4 · Cited by 89
Gale, M., Sayegh, J., Cao, J. P., Norcia, M., Gareiss, P. C., Hoyer, D., Merkel, J. S., & Yan, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.9539 · Cited by 88
SMAD4 Suppresses WNT-Driven Dedifferentiation and Oncogenesis in the Differentiated Gut Epithelium
Perekatt, A. O., Shah, P., Cheung, S., Jariwala, N. H., Wu, A., Gandhi, V., Kumar, N., Feng, Q., Patel, N. R., Chen, L., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0043 · Cited by 87
Lien, S.-C., Usami, S., Chien, S., & Chiu, J. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.10.013 · Cited by 84
TGF‐β Control of Adaptive Immune Tolerance: A Break From Treg Cells
Liu, M., Li, S., & Li, M. O. (2018) · BioEssays · doi:10.1002/bies.201800063 · Cited by 80
Doherty, M. R., Parvani, J. G., Tamagno, I., Junk, D. J., Bryson, B. L., Cheon, H. J., Stark, G. R., & Jackson, M. W. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1136-x · Cited by 79
Banerji, U., van Doorn, L., Papadatos-Pastos, D., Kristeleit, R. S., Debnam, P. M., Tall, M., Stewart, A., Raynaud, F. I., Garrett, M. D., Toal, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3165 · Cited by 77
Hudes, G., Tagawa, S., Whang, Y., Qi, M., Qin, X., Puchalski, T., Reddy, M., Cornfeld, M., & Eisenberger, M. (2013) · Investigational new drugs · doi:10.1007/s10637-012-9857-z · Cited by 71
Ferrari, A. C., Alumkal, J. J., Stein, M. N., Taplin, M., Babb, J. S., Barnett, E. S., Gómez-Pinillos, A., Liu, X., Moore, D. F., DiPaola, R. S., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1589 · Cited by 71
Emerging Role of Histone Acetyltransferase in Stem Cells and Cancer
Trisciuoglio, D., Martile, M. D., & Bufalo, D. D. (2018) · Stem Cells International · doi:10.1155/2018/8908751 · Cited by 70
Deciphering the Code of the Cancer Genome: Mechanisms of Chromosome Rearrangement
Willis, N. A., Rass, E., & Scully, R. (2015) · Trends in cancer · doi:10.1016/j.trecan.2015.10.007 · Cited by 68
Han, J., Lee, S. H., Lee, G. K., Yun, T., Lee, Y. J., Hwang, K. H., Kim, J. Y., & Kim, H. T. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2664-9 · Cited by 64
Adipocyte activation of cancer stem cell signaling in breast cancer
Wolfson, B., Eades, G., & Zhou, Q. (2015) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v6.i2.39 · Cited by 63
Zhang, M., Cong, Q., Zhang, X., Zhang, M., Lu, Y., & Xu, C. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27369 · Cited by 62
From a novel HTS hit to potent, selective, and orally bioavailable KDM5 inhibitors
Liang, J., Labadie, S. S., Zhang, B., Ortwine, D. F., Patel, S. D., Vinogradova, M. V., Kiefer, J. R., Mauer, T., Gehling, V. S., Harmange, J.-C., et al. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.05.016 · Cited by 61
Cancer cell adaptability: turning ribonucleoprotein granules into targets
Lavalée, M., Curdy, N., Laurent, C., Fournié, J., & Franchini, D. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.05.006 · Cited by 61
Begum, A., McMillan, R. H., Chang, Y.-T., Penchev, V. R., Rajeshkumar, N. V., Maitra, A., Goggins, M., Eshelman, J. R., Wolfgang, C. L., Rasheed, Z. A., et al. (2019) · Pancreas · doi:10.1097/mpa.0000000000001249 · Cited by 60
Du, Y., Shao, H., Moller, M. G., Prokupets, R., Tse, Y. T., & Liu, Z. (2019) · Stem Cells · doi:10.1002/stem.3013 · Cited by 58
Knockdown of Lymphoid Enhancer factor 1 Inhibits Colon Cancer Progression In Vitro and In Vivo
Wang, W., Yao, Y., Jiang, L., Hu, T., Ma, J., Liao, Z., Yao, J., Li, D.-F., Wang, S., & Nan, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076596 · Cited by 55
Taming the Notch Transcriptional Regulator for Cancer Therapy
Tamagnone, L., Zacchigna, S., & Rehman, M. (2018) · Molecules · doi:10.3390/molecules23020431 · Cited by 49
Immunotherapy for pancreatic cancer: A long and hopeful journey
Xu, J., Wang, L., Cheng, Y., Zhang, G., Hu, S., Zhou, B., & Zhan, H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.03.040 · Cited by 48
The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death
Castelli, V., Giordano, A., Benedetti, E., Giansanti, F., Quintiliani, M., Cimini, A., & d’Angelo, M. (2021) · Cancers · doi:10.3390/cancers13020328 · Cited by 48
Migault, M., Sapkota, S., & Bracken, C. P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04199-0 · Cited by 48
Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer
Constantin, T. A., Greenland, K. K., Varela‐Carver, A., & Bevan, C. L. (2022) · Oncogene · doi:10.1038/s41388-022-02347-1 · Cited by 48
Chromosomal Instability in Genome Evolution: From Cancer to Macroevolution
Comaills, V., & Castellano‐Pozo, M. (2023) · Biology · doi:10.3390/biology12050671 · Cited by 46
Xin, H., Kong, Y., Jiang, X., Wang, K., Qin, X., Miao, Z., Zhu, Y. Z., & Tan, W. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13025fp · Cited by 39
Deng, H., Ravikumar, T. S., & Yang, W. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.06.008 · Cited by 38
An Ovol2‐Zeb1 transcriptional circuit regulates epithelial directional migration and proliferation
Haensel, D., Sun, P., MacLean, A., Ma, X.-H., Zhou, Y., Stemmler, M., Brabletz, S., Berx, G., Plikus, M., Nie, Q., et al. (2018) · EMBO Reports · doi:10.15252/embr.201846273 · Cited by 38
Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma
Gholiha, A. R., Hollander, P., Glimelius, I. C., Hedström, G., Molin, D. L., Hjalgrim, H., Smedby, K. E. E., Hashemi, J., Amini, R., & Enblad, G. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003664 · Cited by 38
GRHL2-controlled gene expression networks in luminal breast cancer
Wang, Z., Coban, B., Wu, H., Chouaref, J., Daxinger, L., Paulsen, M. T., Ljungman, M. E., Smid, M., Martens, J. W. M., & Danen, E. H. J. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-022-01029-5 · Cited by 38
Holden, D. W. (2015) · Science · doi:10.1126/science.1262033 · Cited by 34
Proteomic identification of a marker signature for MAPKi resistance in melanoma
Paulitschke, V., Eichhoff, O. M., Gerner, C., Paulitschke, P., Bileck, A., Mohr, T. T., Cheng, P. F., Leitner, A., Guenova, E., Saulīte, I., et al. (2019) · The EMBO Journal · doi:10.15252/embj.201695874 · Cited by 34
Panchy, N. L., Azeredo-Tseng, C., Luo, M., Randall, N., & Hong, T. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01479 · Cited by 33
Clinical & Experimental Metastasis
(2013) · Clinical & Experimental Metastasis · doi:10.1007/10585.1573-7276 · Cited by 33
Cancer as a biophysical disease: Targeting the mechanical-adaptability program
Nguyen, L. T. S., Jacob, M. A. C., Parajón, E., & Robinson, D. N. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2022.04.039 · Cited by 33
Small molecule KDM4s inhibitors as anti-cancer agents
Lin, H., Li, Q., Li, Q., Zhu, J., Gu, K., Jiang, X., Hu, Q., Feng, F., Qu, W., Chen, Y., et al. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1455676 · Cited by 32
Tumor cell plasticity: the challenge to catch a moving target
Schwitalla, S. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0943-1 · Cited by 30
Jackson, H. L., Granger, D., Jones, G. C., Anderson, L., Friel, S. L., Rycroft, D., Fieles, W. E., Tunstead, J. R., Steward, M., Wattam, T. A., et al. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0088 · Cited by 28
Tumors smother their epigenome
Thienpont, B., Dyck, L. V., & Lambrechts, D. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2016.1240549 · Cited by 28
Cancer plasticity: Investigating the causes for this agility
Saha, S., Pradhan, N., Neha, B., Mahadevappa, R., Minocha, S., & Kumar, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.12.005 · Cited by 28
The role of bone morphogenetic protein-5 (BMP-5) in human nephrosclerosis
Bramlage, C. P., Muller, G. A., Tampe, B., Bevanda, J., Maatouk, I., Koziolek, M. J., Lange, K., Ahrens, K., Schmid, H., Cohen, C. D., et al. (2011) · Journal of Nephrology · doi:10.5301/jn.2011.6330 · Cited by 20
Emerging Role of Chimeric RNAs in Cell Plasticity and Adaptive Evolution of Cancer Cells
Mukherjee, S., Heng, H. H., & Frenkel‐Morgenstern, M. (2021) · Cancers · doi:10.3390/cancers13174328 · Cited by 19
RB1, Cancer Lineage Plasticity, and Therapeutic Resistance
Zhang, L., & Goodrich, D. W. (2022) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-070120-092840 · Cited by 15
Pons, M., Cigudosa, J. C., Rodríguez, S., Bella, J. L., González, C., Gamallo, C., & Quintanilla, M. (2005) · Oncogene · doi:10.1038/sj.onc.1208903 · Cited by 14
Noncoding RNAs in Cancer Cell Plasticity
Xu, J., & Liu, S. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_6 · Cited by 14
Phenotypic plasticity of melanocytes derived from human adult skin
Vidács, D. L., Veréb, Z., Bozó, R., Flink, L. B., Polyánka, H., Németh, I. B., Póliska, S., Papp, B. T., Manczinger, M., Gáspár, R., et al. (2021) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13012 · Cited by 14
Cited by
Shah, S., & D’Souza, G. G. M. (2025) · Cells · doi:10.3390/cells14100732 · Cited by 83
Li, Q., He, G., Yu, Y., Li, X., Peng, X., & Yang, L. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04061-z · Cited by 64
Overcoming Barriers in Cancer Biology Research: Current Limitations and Solutions
(2025) · doi:10.3390/cancers17132102 · Cited by 44
Metadata
- Authors
- Bhat, G. R., Sethi, I., Sadida, H. Q., Rah, B., Mir, R., Algehainy, N., Albalawi, I. A., Masoodi, T., Subbaraj, G. K., Jamal, F., Singh, M., Kumar, R., Macha, M. A., Uddin, S., Akil, A. S. A.-S., Haris, M., & Bhat, A. A.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2024-02-08
- Volume
- 43
- Issue
- 1
- Pages
- 197-228
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W4391649973
- Cited by
- 281
- References
- 251
- FWCI
- 22.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.